For instance, the European Medicines Agency (EMA) approved Biocon's insulin glargine biosimilar, Semglee, in September 2023 ...

The efficacy benefits of biphasic insulin aspart formulation (BIAsp 30) in patients with diabetes mellitus have been reported in several studies. BIAsp 30 has been shown to be more effective in ...

WAC prices for Zituvimet and Zituvio are not readily available. CVS Caremark has also added the unbranded biosimilar to Sanofi’s Lantus, which treats type 2 diabetes in adults and type 1 diabetes in ...

The results showed that liraglutide and insulin glargine were the most effective at keeping A1C levels below 7%, the target range for many people with diabetes. Glimepiride had a smaller effect ...

Original Medicare (Part A and Part B) does not cover insulin glargine (Basagalar). Medicare Part C and Part D cover some forms of insulin if you have diabetes, but coverage depends on the plan‘s ...